Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions
The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Cortical superficial siderosis describes a distinct pattern of blood-breakdown product deposition limited to cortical sulci over the convexities of the cerebral hemispheres, sparing the brainstem, cerebellum and spinal cord. Although cortical superficial siderosis has many possible causes, it is emerging as a key feature of cerebral amyloid angiopathy, a common and important age-related cerebral small vessel disorder leading to intracerebral haemorrhage and dementia. In cerebral amyloid angiopathy cohorts, cortical superficial siderosis is associated with characteristic clinical symptoms, including transient focal neurological episodes; preliminary data also suggest an association with a high risk of future intracerebral haemorrhage, with potential implications for antithrombotic treatment decisions. Thus, cortical superficial siderosis is of relevance to neurologists working in neurovascular, memory and epilepsy clinics, and neurovascular emergency services, emphasizing the need for appropriate blood-sensitive magnetic resonance sequences to be routinely acquired in these clinical settings. In this review we focus on recent developments in neuroimaging and detection, aetiology, prevalence, pathophysiology and clinical significance of cortical superficial siderosis, with a particular emphasis on cerebral amyloid angiopathy. We also highlight important areas for future investigation and propose standards for evaluating cortical superficial siderosis in research studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of cSS in non-demented elderly subjects is around 0.5%, 142,144 whereas the frequency in patients recruited through memory clinics is much higher ranging from 2% to 6%. 145-147”
From Vascular Cognitive Impairment (2017) · cites this paper as [142]
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · cited 2×
“Future studies should explore if cSS is a clinically important feature for haemorrhagic risk assessment in older patients without symptoms, in the context of anticoagulants, including recently approved newer direct oral anticoagulants (dabigatran, rivaroxaban, apixaban, edoxaban) (Connolly et al., 2009; Granger et al.…”
BackgroundRivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544
Self-citationEdoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Self-citationSusceptibility weighted imaging (SWI)
Haacke, E. M., Xu, Y., Cheng, Y. N., & Reichenbach, J. R. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20198 · Cited by 1,582
Dreier, J. P. (2011) · Nature Medicine · doi:10.1038/nm.2333 · Cited by 1,132
Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1
Haacke, E. M., Mittal, S., Wu, Z., Neelavalli, J., & Cheng, Y.-C. N. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1400 · Cited by 1,113
Research works printed but not linked: 1
- Join-Lambert, 2013, Are silent ischemic infarcts in cerebral amyloid angiopathy associated with subarachnoid hemorrhage?, Cerebrovas Dis, 35, 409
Cited by
Charidimou, A., Boulouis, G., Frosch, M. P., Baron, J.-C., Pasi, M., Albucher, J. F., Banerjee, G., Barbato, C., Bonneville, F., Brandner, S., et al. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00208-3 · Cited by 723
Self-citationCerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions
Magid-Bernstein, J., Girard, R., Polster, S., Srinath, A., Romanos, S., Awad, I. A., & Sansing, L. H. (2022) · Circulation Research · doi:10.1161/circresaha.121.319949 · Cited by 666
Spontaneous subarachnoid haemorrhage
Claassen, J., & Park, S. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00938-2 · Cited by 587
Dichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
Emerging concepts in sporadic cerebral amyloid angiopathy
Charidimou, A., Boulouis, G., Gurol, M. E., Ayata, C., Bacskai, B. J., Frosch, M. P., Viswanathan, A., & Greenberg, S. M. (2017) · Brain · doi:10.1093/brain/awx047 · Cited by 555
Self-citationDiagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria
Greenberg, S. M., & Charidimou, A. (2018) · Stroke · doi:10.1161/strokeaha.117.016990 · Cited by 439
Self-citationAuriel, E., Charidimou, A., Gurol, M. E., Ni, J., Van Etten, E. S., Martinez-Ramirez, S., Boulouis, G., Piazza, F., DiFrancesco, J. C., Frosch, M. P., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4078 · Cited by 359
Self-citationInoue, Y., Shue, F., Bu, G., & Kanekiyo, T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00640-5 · Cited by 329
MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy
Charidimou, A., Boulouis, G., Pasi, M., Auriel, E., van Etten, E. S., Haley, K., Ayres, A., Schwab, K. M., Martinez-Ramirez, S., Goldstein, J. N., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003746 · Cited by 313
Self-citationCerebral Microbleeds: Imaging and Clinical Significance
Haller, S., Vernooij, M. W., Kuijer, J. P. A., Larsson, E.-M., Jäger, H. R., & Barkhof, F. (2018) · Radiology · doi:10.1148/radiol.2018170803 · Cited by 308
Self-citationLewczuk, P., Riederer, P., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramirez, A., Parnetti, L., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 307
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 305
Cerebrovascular disease in ageing and Alzheimer’s disease
Love, S., & Miners, J. S. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1522-0 · Cited by 299
Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study
Moulin, S., Labreuche, J., Bombois, S., Rossi, C., Boulouis, G., Hénon, H., Duhamel, A., Leys, D., & Cordonnier, C. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00130-7 · Cited by 269
Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis
Charidimou, A., Imaizumi, T., Moulin, S., Biffi, A., Samarasekera, N., Yakushiji, Y., Peeters, A., Vandermeeren, Y., Laloux, P., Baron, J.-C., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004259 · Cited by 267
Self-citationWilson, D., Ambler, G., Shakeshaft, C., Brown, M. M., Charidimou, A., Al-Shahi Salman, R., Lip, G. Y. H., Cohen, H., Banerjee, G., Houlden, H., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30145-5 · Cited by 254
Self-citationInteraction between cerebrovascular disease and Alzheimer pathology
Saito, S., & Ihara, M. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000239 · Cited by 69
Metadata
- Authors
- Charidimou, A., Linn, J., Vernooij, M. W., Opherk, C., Akoudad, S., Baron, J.-C., Greenberg, S. M., Jäger, H. R., & Werring, D. J.
- Affiliations
- Massachusetts General Hospital (US)
- Ludwig-Maximilians-Universität München (DE)
- Erasmus MC (NL)
- SLK-Kliniken Heilbronn (DE)
- Inserm (FR)
- National Hospital for Neurology and Neurosurgery (GB)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-06-26
- Volume
- 138
- Issue
- 8
- Pages
- 2126-2139
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2140732046
- Cited by
- 385
- References
- 108
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 34 · 2023: 37 · 2022: 41 · 2021: 31 · 2020: 43 · 2019: 51 · 2018: 30 · 2017: 35 · 2016: 24 · 2015: 5
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research
- British Heart Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- cortical superficial siderosis, cerebral amyloid angiopathy, intracerebral hemorrhage, cerebral small vessel disease, dementia, antithrombotic therapy, pathophysiology, etiology, prevalence
- MeSH terms
- Animals, Brain, Cerebral Hemorrhage, Humans, Magnetic Resonance Imaging, Siderosis, Prevalence, Cerebral Amyloid Angiopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.